SCHEMBL6447784

SCHEMBL6447784

CCc1c(C(=O)O)ccc(OC)c1OCCCN1CCOCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.60
CYP2D6 P10635 2/20 0.60
KDM4E B2RXH2 2/20 0.53
TDP1 Q9NUW8 1/20 0.53
POLB P06746 1/20 0.48
KEAP1 Q14145 1/20 0.48
NFE2L2 Q16236 1/20 0.48
CNR2 P34972 1/20 0.47
LMNA P02545 3/20 0.47
ALDH1A1 P00352 3/20 0.46
HRH3 Q9Y5N1 2/20 0.46
MAPK1 P28482 2/20 0.46
CYP1A2 P05177 1/20 0.46
CHRM2 P08172 1/20 0.46
CHRM1 P11229 1/20 0.46
HTR2A P28223 1/20 0.46
SCN1A P35498 1/20 0.46
HTR2B P41595 1/20 0.46
KCNH2 Q12809 1/20 0.46
SCN2A Q99250 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4047895 0.91 KDM4E (0.53) TSHRCYP2D6KDM4ETDP1POLB
SCHEMBL7718571 0.84 CYP2D6 (0.51) TSHRCYP2D6KDM4ETDP1POLB
SCHEMBL7718548 0.81 CYP2D6 (0.50) TSHRCYP2D6KDM4ETDP1POLB
SCHEMBL6442664 0.78 KDM4E (0.47) TSHRCYP2D6KDM4ETDP1POLB
SCHEMBL31620997 0.77 KDM4E (0.58) TSHRCYP2D6KDM4ETDP1POLB
SCHEMBL4043734 0.76 CYP2D6 (0.48) TSHRCYP2D6KDM4ETDP1POLB
SCHEMBL5494919 0.75 KDM4E (0.66) TSHRCYP2D6KDM4ETDP1KEAP1
SCHEMBL6437918 0.75 KDM4E (0.52) TSHRCYP2D6KDM4ETDP1KEAP1
SCHEMBL3782773 0.74 MAPT (0.62) TSHRKDM4ETDP1CNR2LMNA
SCHEMBL21741656 0.74 KDM4E (0.64) TSHRCYP2D6KDM4ETDP1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263503-B1 USE OF CYANOQUINOLINES FOR TREATING OR INHIBITING COLONIC POLYPS WYETH CORP (US) 2005-11-02 EP disclosed
EP-1117659-B1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS WYETH CORP (US) 2003-12-03 EP disclosed
EP-0973746-B1 SUBSTITUTED 3-CYANO QUINOLINES WYETH CORP (US) 2003-09-24 EP disclosed
EP-1263503-A2 USE OF CYANOQUINOLINES FOR TREATING OR INHIBITING COLONIC POLYPS AMERICAN CYANAMID COMPANY (US) 2002-12-11 EP disclosed
WO-2001068186-A2 USE OF CYANOQUINOLINES FOR TREATING OR INHIBITING COLONIC POLYPS AMERICAN CYANAMID COMPANY (US) 2001-09-20 WO disclosed
US-6288082-B1 COMPOUNDS SUCH AS 6,7-DIETHOXY-4-(INDAN-5-YLAMINO) -QUINOLINE-3-CARBONITRILE USED AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYCSTIC KIDNEY DISEASE AMERICAN CYANAMID COMPANY 2001-09-11 US disclosed
EP-1117659-A1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS American Cyanamid Company (US) 2001-07-25 EP disclosed
WO-2000018761-A1 SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-04-06 WO disclosed
US-6002008-A Substituted 3-cyano quinolines AMERICAN CYANAMID COMPANY 1999-12-14 US disclosed